Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
HLA class Ι molecules can communicate a range of cellular alterations (mutations, changes in protein copy number, aberrant post-translational modifications, or pathogen proteins) to CD8+ T lymphocytes in the form of HLA peptide ligands. At any given moment, tens of thousands of different self and foreign HLA class Ι peptides may be presented on the cell surface by HLA class Ι complexes. Due to the enormous biochemical diversity and low abundance of each of these peptides, HLA ligandome analysis presents unique challenges. Even with advances in enrichment strategies and MS instrumentation and fragmentation, sufficient ligandome depth for identification of viral pathogens and immuno therapeutically important tumor neo-antigens is still not routinely achievable. In this study, we evaluated two pre-fractionation techniques, high-pH reversed-phase and strong cation exchange, for the complementary analyses of HLA class Ι peptide ligands. We observe that pre-fractionation substantially extends the detectable HLA class Ι ligandome but also creates an identification bias. We thus advocate a rational choice between high-pH reversed-phase or strong cation exchange pre-fractionation for deeper HLA class Ι ligandome analysis, depending on the HLA locus, allele, or peptide ligand modification in question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unintentionally, many MHC immunopeptidome analyses are biased due to technical limitations.7,8”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [7]
In the citing paper
“most immunopeptidomic laboratories do not routinely add a cysteine protecting reagent during cell lysis for MHC-IAC.7,8,18,24,27,49,54−57”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [7]
In the citing paper
“Most immunopeptidomic studies either do not consider cysteine modifications18,22,52,54−56 or use cysteinylation as the only cysteine modification allowed in database searches.7,24,27,57”
From Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome (2021) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Scally, S. W., Petersen, J., Law, S. C., Dudek, N. L., Nel, H. J., Loh, K. L., Wijeyewickrema, L. C., Eckle, S. B. G., van Heemst, J., Pike, R. N., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131241 · Cited by 429
Zheng, X., Baker, H., Hancock, W. S., Fawaz, F., McCaman, M., & Pungor, E. (2006) · Biotechnology Progress · doi:10.1021/bp060121o · Cited by 346
Zarling, A. L., Ficarro, S. B., White, F. M., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1755 · Cited by 213
Mohammed, F., Cobbold, M., Zarling, A. L., Salim, M., Barrett-Wilt, G. A., Shabanowitz, J., Hunt, D. F., Engelhard, V. H., & Willcox, B. E. (2008) · Nature Immunology · doi:10.1038/ni.1660 · Cited by 155
Research works printed but not linked: 29
- Schumacher, 2015, Neoantigens in cancer immunotherapy, Science, 348, 69, 10.1126/science.aaa4971 · DOI · Paper page
- Bassani-Sternberg, 2016, Mass spectrometry-based antigen discovery for cancer immunotherapy, Curr. Opin. Immunol., 41, 9, 10.1016/j.coi.2016.04.005 · DOI
- Marino, 2015, Extended O-GlcNAc on HLA Class-I-Bound Peptides, J. Am. Chem. Soc., 137, 10922, 10.1021/jacs.5b06586 · DOI · Paper page
- Marino, 2017, Arginine (Di)methylated Human Leukocyte Antigen Class I Peptides Are Favorably Presented by HLA-B*07, J. Proteome Res., 16, 34, 10.1021/acs.jproteome.6b00528 · DOI
- Alpizar, 2017, A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens, Mol. Cell. Proteomics, 16, 181, 10.1074/mcp.M116.063800 · DOI · Paper page
- Mommen, 2014, Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD), Proc. Natl. Acad. Sci. U. S. A., 111, 4507, 10.1073/pnas.1321458111 · DOI · Paper page
- Gilar, 2005, Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions, J. Sep. Sci., 28, 1694, 10.1002/jssc.200500116 · DOI · Paper page
- Gilar, 2005, Orthogonality of separation in two-dimensional liquid chromatography, Anal. Chem., 77, 6426, 10.1021/ac050923i · DOI · Paper page
- Essader, 2005, A comparison of immobilized pH gradient isoelectric focusing and strong-cation-exchange chromatography as a first dimension in shotgun proteomics, Proteomics, 5, 24, 10.1002/pmic.200400888 · DOI · Paper page
- Delmotte, 2007, Two-dimensional reversed-phase x ion-pair reversed-phase HPLC: an alternative approach to high-resolution peptide separation for shotgun proteome analysis, J. Proteome Res., 6, 4363, 10.1021/pr070424t · DOI
- Yang, 2012, High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis, Expert Rev. Proteomics, 9, 129, 10.1586/epr.12.15 · DOI · Paper page
- Wang, 2015, An off-line high pH reversed-phase fractionation and nano-liquid chromatography-mass spectrometry method for global proteomic profiling of cell lines, J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 974, 90, 10.1016/j.jchromb.2014.10.031 · DOI
- Batth, 2014, Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics, J. Proteome Res., 13, 6176, 10.1021/pr500893m · DOI · Paper page
- Barnstable, 1978, Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis, Cell, 14, 9, 10.1016/0092-8674(78)90296-9 · DOI · Paper page
- Vizcaino, 2016, 2016 update of the PRIDE database and its related tools, Nucleic Acids Res., 44, D447, 10.1093/nar/gkv1145 · DOI · Paper page
- Andreatta, 2016, Gapped sequence alignment using artificial neural networks: application to the MHC class I system, Bioinformatics, 32, 511, 10.1093/bioinformatics/btv639 · DOI · Paper page
- Talmage, 1957, The primary equilibrium between antigen and antibody, Ann. N. Y. Acad. Sci., 70, 82, 10.1111/j.1749-6632.1957.tb35380.x · doi:10.1111/j.1749-6632.1957.tb35380.x
- Reverberi, 2007, Factors affecting the antigen-antibody reaction, Blood Transfus, 5, 227, 10.2450/2007.0047-07 · doi:10.2450/2007.0047-07 · Paper page
- Andreatta, 2017, GibbsCluster: unsupervised clustering and alignment of peptide sequences, Nucleic Acids Res., 45, W458, 10.1093/nar/gkx248 · DOI · Paper page
- Zarling, 2006, Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy, Proc. Natl. Acad. Sci. U. S. A., 103, 14889, 10.1073/pnas.0604045103 · DOI · Paper page
- Beausoleil, 2004, Large-scale characterization of HeLa cell nuclear phosphoproteins, Proc. Natl. Acad. Sci. U. S. A., 101, 12130, 10.1073/pnas.0404720101 · DOI · Paper page
- Amanchy, 2007, A curated compendium of phosphorylation motifs, Nat. Biotechnol., 25, 285, 10.1038/nbt0307-285 · DOI · Paper page
- James, 2010, HLA-DR1001 presents ″altered-self″ peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets, Arthritis Rheum., 62, 2909, 10.1002/art.27594 · DOI
- Nguyen, 2016, Immune recognition of citrullinated epitopes, Immunology, 149, 131, 10.1111/imm.12640 · DOI
- Seward, 2011, Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis, Mol. Cell. Proteomics, 10, M110002477, 10.1074/mcp.M110.002477 · doi:10.1074/mcp.m110.002477
- Ting, 2018, The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis, J. Biol. Chem., 293, 3236, 10.1074/jbc.RA117.001013 · DOI · Paper page
- Union, 2002, Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay, Arthritis Rheum., 46, 1185, 10.1002/art.10229 · DOI
- Andersen, 1999, Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL, J. Immunol, 163, 3812, 10.4049/jimmunol.163.7.3812 · DOI · Paper page
- Petersen, 2009, Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes, Proc. Natl. Acad. Sci. U. S. A., 106, 2776, 10.1073/pnas.0812901106 · DOI · Paper page
Cited by
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D.-Y., Gallagher, K. M. E., Bauer, M. R., Taylor, H. B., Dunn, W. A., Tarr, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.046 · Cited by 147
Sturm, T., Sautter, B., Wörner, T. P., Stevanović, S., Rammensee, H.-G., Planz, O., Heck, A. J. R., & Aebersold, R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00386 · Cited by 63
Self-citation
Metadata
- Authors
- Demmers, L. C., Heck, A. J. R., & Wu, W.
- Affiliations
- Utrecht University , , Padualaan 8 , ,
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-02-20
- Volume
- 18
- Issue
- 4
- Pages
- 1634-1643
- ISSN
- 1535-3893
- 1535-3907
- Cited by
- 27
- References
- 5
- Language
- en
- Funders
- Horizon 2020 Framework Programme (686547)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (184.032.201, ICI00003)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome. https://app.cochat.ai/papers/10.1021/acs.jproteome.8b00821
- The paper
- Demmers, L. C., Heck, A. J. R., & Wu, W. (2019). Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.8b00821
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.